Grindeks is an international pharmaceutical company based in Latvia. Established in 1946, the company specializes in research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. Its core therapeutic areas include cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindeks' mission to "make people’s lives healthier and easier" is reflected in its commitment to providing simple and innovative solutions to improve the quality of life. While there is no publicly disclosed information about the latest investment or investors, Grindeks' focus on critical medical areas positions it as a potential candidate for strategic partnerships and investments in the pharmaceutical and healthcare industries.
General Information
BounceWatch is an independent company data service, not affiliated with Grindeks. To contact Grindeks, visit grindeks.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Latvia Market
Manufacturing
About Grindeks
Taxonomy: pharmaceuticals, medicine, development, sales, cardiovascular medicine, central nervous system medicine, anti-cancer medicine, diabetes medicine, active pharmaceutical ingredients, quality manufacturing practice, international, innovation
No funding data available for Grindeks yet.
Grindeks Alternatives & Competitors
Human Health Care Is Our Mission
South African pharmaceutical manufacturer specialising in medicines used by zoo and wildlife veterin...
FAQ About Grindeks
Source: BounceWatch company record for Grindeks, https://bouncewatch.com/company/grindeks, updated 6 January 2025. When citing, please name BounceWatch and link this page.